Jon Congleton
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $16.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 75,000528,621 held (−12%) | $25.46 | $1.9M | -8.2% |
| Jul 15SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 10,700603,621 held (−2%) | $27.24 | $291K | -14.2% |
| Jun 30SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 58,000631,321 held (−8%) | $25.94 | $1.5M | -9.9% |
| Jun 30SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 17,000614,321 held (−3%) | $26.82 | $456K | -12.9% |
| Apr 15SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 15,730689,321 held (−2%) | $26.83 | $422K | -12.9% |
| Apr 2SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 19,364760,687 held (−2%) | $25.50 | $494K | -8.4% |
| Apr 2SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 55,183705,504 held (−7%) | $26.54 | $1.5M | -11.9% |
| Apr 2SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 453705,051 held (−0%) | $27.05 | $12K | -13.6% |
| Jan 13SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 9,119646,268 held (−1%) | $32.21 | $294K | -27.4% |
| Jan 13SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 7,117639,151 held (−1%) | $33.15 | $236K | -29.5% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 12,806818,499 held (−2%) | $41.64 | $533K | -43.9% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 8,862809,637 held (−1%) | $42.31 | $375K | -44.8% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 4,000805,637 held (−0%) | $43.50 | $174K | -46.3% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 29,207776,430 held (−4%) | $45.20 | $1.3M | -48.3% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 112,275664,155 held (−14%) | $45.83 | $5.1M | -49.0% |
| Nov 13SEC | MLYSMineralys Therapeutics, Inc. | Sell | 32,850631,305 held (−5%) | $46.89 | $1.5M | -50.2% |
| Oct 15SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 13,548832,857 held (−2%) | $42.63 | $578K | -45.2% |
| Oct 15SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 1,552831,305 held (−0%) | $43.03 | $67K | -45.7% |
- Sell
CEO Jon Congleton sold $1.9M of MLYS at $25.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jon Congleton sold $291K of MLYS at $27.24 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jon Congleton sold $1.5M of MLYS at $25.94 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jon Congleton sold $456K of MLYS at $26.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jon Congleton sold $422K of MLYS at $26.83 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Jon Congleton sold $494K of MLYS at $25.50 — pre-scheduled 10b5-1 plan sale.